[TimAlerts] $STML nice positive data

[TimAlerts] $STML http://finance.yahoo.com/news/stemline-therapeutics-presents-clinical-ongoing-162300246.html "The data being presented demonstrate that multiple consecutive cycles of SL-401 produced an 86% (12/14) overall response rate (ORR) in BPDCN, with a 100% (9/9) ORR in first-line BPDCN and a 60% (3/5) ORR in relapsed/refractory BPDCN."

[TimAlerts] $STML released drug data 4 minutes ago

[TimAlerts] $STML data release

[TimAlerts] $STML moving

[TimAlerts] $STML spike

[TimAlerts] $STML has news for earning. let see if it can go HIGH.